This difference was not significant (p = 0.55, Figure 1A ), nor was there a significant difference in maximum percent weight loss between exenatide and diet super responders (p = 0.62)
The IRA introduces a pre-LOE price reduction event that changes the economics for generic and biosimilar entrants
Knowledge is power, and we want you to leave feeling informed about your health decisions
P = 0.02), which was mostly attributable to the higher incidence of cardiac disorders and infections in the placebo group, but gastrointestinal disorders were more common among patients receiving semaglutide
A new challenge has been presented with the steep rise in the use of GLP-1 agonists and their potential to induce delayed gastric emptying, which is associated with a high risk of potentially catastrophic complications including pulmonary aspiration, aspiration pneumonitis, and pneumonia
Tamiflu vs Xofluza: Different Drugs, Similar Problems While mechanistically different, Tamiflu and Xofluza share several issues: Modest clinical benefit Resistance development Overreliance as a primary strategy Distraction from immune-supportive care Neither drug meaningfully changes the natural history of influenza for most people